Viewing Study NCT00405366

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2026-01-01 @ 8:28 AM
Study NCT ID: NCT00405366
Status: COMPLETED
Last Update Posted: 2017-04-18
First Post: 2006-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage II renal cell cancer View
None stage III renal cell cancer View
None stage IV renal cell cancer View